114 results
SC 14D9/A
GRNA
GreenLight Biosciences Inc
11 Jul 23
Tender offer solicitation (amended)
9:12am
and December 31, 2028 which resulted in estimated tax expenses of $304, $502 and $1,239, respectively, in each of those years. Roth derived the tax … expense numbers by applying a 21% corporate tax rate to 20% of the projected EBIT value in each corresponding fiscal year. (v) Roth previously used
SC 14D9/A
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation (amended)
4:05pm
with tax withholding or payment of the exercise price for the exercise of Company stock options). Under the DGCL and the terms of the Merger … will be a taxable transaction to the unaffiliated Company stockholders for U.S. federal income tax purposes.
Some of the Company’s directors and executive officers
SC 14D9
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
with tax withholding or payment of the exercise price for the exercise of Company stock options). Under the DGCL and the terms of the Merger Agreement … transaction to the unaffiliated Company stockholders for U.S. federal income tax purposes.
Some of the Company’s directors and executive officers have
SC 14D9
EX-99
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
on the Company or the contemplated benefits expected to be derived in the proposed Transaction. We are not legal, tax, accounting or regulatory advisors … verification, the assessment of the Company and its legal, tax, accounting and regulatory advisors with respect to legal, tax, accounting and regulatory
SC 14D9
EX-99
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
and risks as well as the legal, tax and accounting consequences of any such transaction. This presentation does not constitute an opinion, and ROTH … assumes that cash flows come in continuously throughout the year. Assumes a valuation date of 06/30/2023. b) B(u) = B(l) / (1+(1-Tax Rate) x Debt
SC TO-T
EX-99
3khwj0qo8ap l2x6x
21 Jun 23
Third party tender offer statement
9:23am
SC TO-T
EX-99
ps0fflt 9p8euia
21 Jun 23
Third party tender offer statement
9:23am
SC TO-T
EX-99
sdnb0wjh
21 Jun 23
Third party tender offer statement
9:23am
SC TO-T
EX-99
5abh8eq9q5 vrwwaq51z
21 Jun 23
Third party tender offer statement
9:23am
8-K
w0paz 8gtel4qkyblhs6
31 May 23
Cost Associated with Exit or Disposal Activities
4:29pm
8-K
EX-2.1
fyo372s0sj58o3g
30 May 23
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
7:11am
424B3
tphnn6mtdi7twr0wg
9 Nov 22
Prospectus supplement
5:27pm
424B3
2e56tugem7c0ii2zbv
12 Oct 22
Prospectus supplement
6:53am
8-K
kq6 endch5w4nvm
12 Oct 22
Cost Associated with Exit or Disposal Activities
6:50am
424B3
apdu40jbi9izuiobq90
6 Oct 22
Prospectus supplement
5:15pm
424B3
r92mzmxu 3p8i
26 Sep 22
Prospectus supplement
4:47pm